These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17177973)

  • 1. IL-9 promotes anti-Mycobacterium leprae cytotoxicity: involvement of IFNgamma.
    Finiasz MR; Franco MC; de la Barrera S; Rutitzky L; Pizzariello G; del Carmen Sasiain M; Renauld JC; Van Snick J; Fink S
    Clin Exp Immunol; 2007 Jan; 147(1):139-47. PubMed ID: 17177973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
    de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD.
    Sasiain MC; de la Barrera S; Fink S; Finiasz M; Alemán M; Fariña MH; Pizzariello G; Valdez R
    Clin Exp Immunol; 1998 Nov; 114(2):196-203. PubMed ID: 9822276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-gamma, IL-6 and IL-4 modulate M. leprae- or PPD-specific cytotoxic T cells in leprosy patients.
    Fink S; de la Barrera S; Minnucci F; Valdez R; Baliña LM; Sasiain MC
    Scand J Immunol; 1993 Dec; 38(6):551-8. PubMed ID: 8256114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK cells modulate the cytotoxic activity generated by Mycobacterium leprae-hsp65 in leprosy patients: role of IL-18 and IL-13.
    de la Barrera S; Finiasz M; Fink S; Ilarregui J; Aleman M; Olivares L; Franco MC; Pizzariello G; del Carmen Sasiain M
    Clin Exp Immunol; 2004 Jan; 135(1):105-13. PubMed ID: 14678270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy.
    Sieling PA; Abrams JS; Yamamura M; Salgame P; Bloom BR; Rea TH; Modlin RL
    J Immunol; 1993 Jun; 150(12):5501-10. PubMed ID: 8515073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility to Mycobacterium leprae of ALY (alymphoplasia) mice and IFN-gamma induction in the culture supernatant of spleen cells.
    Yogi Y; Endoh M; Banba T; Okamura H; Nomaguchi H
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):464-74. PubMed ID: 10347567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
    J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae.
    Misra N; Murtaza A; Walker B; Narayan NP; Misra RS; Ramesh V; Singh S; Colston MJ; Nath I
    Immunology; 1995 Sep; 86(1):97-103. PubMed ID: 7590888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
    Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
    Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients.
    Kaleab B; Ottenoff T; Converse P; Halapi E; Tadesse G; Rottenberg M; Kiessling R
    Eur J Immunol; 1990 Dec; 20(12):2651-9. PubMed ID: 2269329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of host-protective (IFN-gamma), host-impairing (IL-10, IL-13) and inflammatory (TNF-alpha) cytokines by PBMC from leprosy patients stimulated with mycobacterial antigens.
    Machado P; Abrams J; Santos S; Brennan P; Barral A; Barral-Netto M
    Eur J Dermatol; 1998 Mar; 8(2):98-103. PubMed ID: 9649657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-12 amplifies the M. leprae hsp65-cytotoxic response in the presence of tumour necrosis factor-alpha and interferon-gamma generating CD56+ effector cells: interleukin-4 downregulates this effect.
    Aleman M; De La Barrera S; Fink S; Finiasz M; Farina MH; Pizzariello G; Sasiain MD
    Scand J Immunol; 2000 Mar; 51(3):262-70. PubMed ID: 10736095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-2 and IL-12 act in synergy to overcome antigen-specific T cell unresponsiveness in mycobacterial disease.
    de Jong R; Janson AA; Faber WR; Naafs B; Ottenhoff TH
    J Immunol; 1997 Jul; 159(2):786-93. PubMed ID: 9218596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1- and type 2-like lesional skin-derived Mycobacterium leprae-responsive T cell clones are characterized by coexpression of IFN-gamma/TNF-alpha and IL-4/IL-5/IL-13, respectively.
    Verhagen CE; van der Pouw Kraan TC; Buffing AA; Chand MA; Faber WR; Aarden LA; Das PK
    J Immunol; 1998 Mar; 160(5):2380-7. PubMed ID: 9498780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacteria induce CD4+ T cells that are cytotoxic and display Th1-like cytokine secretion profile: heterogeneity in cytotoxic activity and cytokine secretion levels.
    Mutis T; Cornelisse YE; Ottenhoff TH
    Eur J Immunol; 1993 Sep; 23(9):2189-95. PubMed ID: 8103743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and specificity of the enhancing effect of three types of interleukin 2 on T cell responsiveness in 97 lepromatous leprosy patients of mixed ethnic origin.
    Barnass S; Mace J; Steele J; Torres P; Gervasoni B; Ravioli R; Terencio J; Rook GA; Waters MF
    Clin Exp Immunol; 1986 Apr; 64(1):41-9. PubMed ID: 2426020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
    Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA
    J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.